Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer
Clinical trial NCT01959490 · COMPLETED
Trial details
- NCT number
- NCT01959490
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-24
- Primary completion
- 2016-11-11
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.